James Gunn has reportedly discovered the actor to play his huge unhealthy for the Superman sequel, Man of Tomorrow.
Per Deadline, German actor Lars Eidinger, most just lately seen in Netflix’s Jay Kelly, has booked the a part of Brainiac. The villain has been pegged as the most important menace for the movie that seemingly leads to a team-up between Superman and Lex Luthor, and whereas Gunn was previously evasive on in the event that they’re really going through Brainiac, he’s now confirmed it.
“In our worldwide seek for Brainiac in Man of Tomorrow, Lars Eidinger rose to the high,” Gunn wrote on Twitter. “Welcome to the DCU, Lars.”
In our worldwide seek for Brainiac in Man of Tomorrow, Lars Eidinger rose to the high. Welcome to the DCU, Lars. pic.twitter.com/atkWZpG1CT
— James Gunn (@JamesGunn) December 20, 2025
Created by Otto Binder and Al Plastino, Brainiac first debuted in 1958’s Motion Comics #242. Extra typically than not, he’s an android or cyborg with unimaginable intelligence and management over know-how, and in the higher tier of Superman villains alongside Lex and Basic Zod. Most probably know of the villain by way of his repeat appearances all through the DC Animated Universe, live-action reveals like Smallville and Krypton, and extra just lately My Adventures with Superman. (And Suicide Squad: Kill the Justice League, should you do not forget that.) He’s additionally the predecessor to Brainiac 5, a superhero who typically goes up in opposition to his evil ancestor.
Man of Tomorrow shall be the first time Brainiac’s been introduced to movie in live-action, and the movie hits theaters on July 9, 2027.
Need extra io9 information? Try when to anticipate the newest Marvel, Star Wars, and Star Trek releases, what’s subsequent for the DC Universe on film and TV, and all the things you want to find out about the way forward for Doctor Who.
Disclaimer: This article is sourced from external platforms. OverBeta has not independently verified the information. Readers are advised to verify details before relying on them.
